Transmedics
TMDX
224 hedge funds and large institutions have $2.26B invested in Transmedics in 2023 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 81 increasing their positions, 77 reducing their positions, and 16 closing their positions.
156% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 16
91% more call options, than puts
Call options by funds: $35.6M | Put options by funds: $18.6M
28% more capital invested
Capital invested by funds: $1.77B → $2.26B (+$492M)
13% more funds holding
Funds holding: 199 → 224 (+25)
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
2.84% more ownership
Funds ownership: 90.02% → 92.85% (+2.8%)
5% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 77
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$58.3M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$46.1M |
| 3 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$24.2M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$21.4M |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$16.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Ophir Asset Management
Sydney,
Australia
|
-$17.8M |
| 2 |
SCP
Sandhill Capital Partners
Buffalo,
New York
|
-$14.9M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$14.9M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$14.2M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$14M |
TMDX Hedge Fund Activity: Q1 2023 in Review
224 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q1 2023, worth a combined $2.26B — up 28% from $1.77B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new TMDX positions and 16 closed out — a net gain of 25 holders — while 81 added to existing stakes and 77 trimmed.
The largest buyer was Fred Alger Management, adding an estimated $58.3M. The largest seller was Ophir Asset Management, cutting an estimated $17.8M.
- 224 institutional investors held Transmedics (TMDX) as of Q1 2023, up from 199 in Q4 2022.
- Funds reported $2.26B of Transmedics stock for Q1 2023, up 28% quarter-over-quarter.
- 41 funds opened new Transmedics positions in Q1 2023 and 16 closed out, a net change of +25 holders.
- The largest Transmedics buyer in Q1 2023 was Fred Alger Management, an estimated $58.3M added.
- The largest Transmedics seller in Q1 2023 was Ophir Asset Management, an estimated $17.8M sold.
Based on aggregated 13F filings for Q1 2023.